Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Graviton Launches Korean Stock Perpetual Futures, Expands On-Chain RWA Pairs to 74

Graviton Launches Korean Stock Perpetual Futures, Expands On-Chain RWA Pairs to 74

BlockBeatsBlockBeats2026/06/04 10:27

BlockBeats News, June 4th. Decentralized exchange platform Grvt announced the launch of Korean stock perpetual futures contracts, with the first batch covering Samsung, SK Hynix, and Hyundai. Users can trade 24/7 and maintain asset self-custody throughout the trading process.


The launch comes as the Korean stock market leads globally. Driven by the global AI trend and high-bandwidth memory (HBM) demand, the KOSPI index has risen by nearly 100% this year, propelling Korea to become the world's sixth-largest stock market, with Samsung and SK Hynix accounting for about half of the index.


Since February this year, Grvt's real-world assets (RWA) trading pairs have expanded to 74, covering stocks, private companies, ETFs, and commodities (such as OpenAI, Anthropic, NVIDIA, gold, oil, etc.), consistently bringing traditional market assets onto the blockchain. Grvt has stated its intention to further expand global asset coverage, with more assets set to go live soon.


0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage